5-HT1A Agonist therapy (Suven Life Sciences)

N/A

Report date: 2024/10/11 11:20:27
NME

Base Information

Drug Name5-HT1A Agonist therapy (Suven Life Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsDepressive Disorder, Treatment-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSuven Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuven Life Sciences Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A